Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Organovo Holdings (ONVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 148,914
  • Shares Outstanding, K 111,130
  • Annual Sales, $ 4,600 K
  • Annual Income, $ -34,800 K
  • 36-Month Beta 2.88
  • Price/Sales 32.59
  • Price/Cash Flow N/A
  • Price/Book 3.36

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.31 +3.05%
on 07/16/18
1.55 -12.90%
on 06/22/18
-0.16 (-10.60%)
since 06/15/18
3-Month
1.02 +31.71%
on 04/17/18
2.09 -35.41%
on 05/23/18
+0.32 (+31.07%)
since 04/16/18
52-Week
0.91 +48.35%
on 04/04/18
2.65 -49.15%
on 07/17/17
-1.28 (-48.67%)
since 07/14/17

Most Recent Stories

More News
Organovo Reports Fiscal Fourth-Quarter and Full-Year 2018 Results; Company Announces Key Goals for Fiscal-Year 2019

- Lead Investigational New Drug ("IND") program for Alpha-1-antitrypsin deficiency ("A1AT") received FDA's orphan drug designation and is on track for commencing IND-enabling studies in fiscal 2019

ONVO : 1.35 (+0.75%)
5 Top Performing Stocks of the Best ETF of May

Inside the best performing stocks of the top ETF of May - ARKG.

NVTA : 8.31 (+0.24%)
FMI : 136.70 (unch)
CRSP : 60.06 (-8.60%)
ARKG : 30.84 (-2.67%)
NSTG : 15.10 (+0.60%)
ONVO : 1.35 (+0.75%)
5 Top Performing Stocks of the Best ETF of May

Inside the best performing stocks of the top ETF of May - ARKG.

NVTA : 8.31 (+0.24%)
FMI : 136.70 (unch)
CRSP : 60.06 (-8.60%)
ARKG : 30.84 (-2.67%)
NSTG : 15.10 (+0.60%)
ONVO : 1.35 (+0.75%)
New Research Coverage Highlights Tyson Foods, Windstream, Laredo Petroleum, Idera Pharmaceuticals, Diamondrock Hospitality, and Organovo -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tyson Foods, Inc. (NYSE:TSN),...

LPI : 9.47 (-3.47%)
IDRA : 0.99 (-1.98%)
DRH : 12.31 (-0.24%)
WIN : 4.35 (-3.76%)
ONVO : 1.35 (+0.75%)
TSN : 65.86 (-0.66%)
Organovo to Present New Preclinical Data for Its Liver Therapeutic Tissue IND-Track Programs at the World Advanced Therapies and Regenerative Medicine Congress

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo") today announced that it will present new preclinical data showing the strong functionality of its liver therapeutic tissue in a second IND-track program...

ONVO : 1.35 (+0.75%)
Organovo and Samsara Sciences Partner with New Manufacturing USA Institute

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo") today announced it has joined a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute ("ARMI"). Headquartered...

ONVO : 1.35 (+0.75%)
Add 5 Stocks With Rising P/E to Your Portfolio

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

WPRT : 2.58 (-1.90%)
CCK : 44.75 (-1.34%)
UFPI : 37.62 (-0.76%)
KOP : 37.45 (+0.13%)
ONVO : 1.35 (+0.75%)
Organovo to Present at 2nd Annual NASH Summit

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo") today announced that it will present at the 2nd Annual NASH Summit in Boston, Ma. on Tuesday, April 24th at 4:00pm ET. Alice Chen, Director of Tissue...

ONVO : 1.35 (+0.75%)
Can The Uptrend Continue for Organovo Holdings (ONVO)?

Investors certainly have to be happy with Organovo Holdings, Inc. (ONVO) and its short term performance

ONVO : 1.35 (+0.75%)
Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo") today announced that along with its collaborators, it has achieved several breakthrough capabilities for its 3D bioprinted tissues. At last week's International...

ONVO : 1.35 (+0.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ONVO with:

Business Summary

Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings,...

See More

Key Turning Points

2nd Resistance Point 1.39
1st Resistance Point 1.37
Last Price 1.35
1st Support Level 1.32
2nd Support Level 1.29

See More

52-Week High 2.65
Fibonacci 61.8% 1.99
Fibonacci 50% 1.78
Fibonacci 38.2% 1.58
Last Price 1.35
52-Week Low 0.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar